Candel Therapeutics appoints Maria Ostrovsky as general counsel
CADL•Candel Therapeutics appointed Maria Ostrovsky as general counsel in October, effective November 3, 2026. The company also appointed Martine Zimmermann to its board, effective September 8, 2026.
1. Leadership appointments
Candel Therapeutics appointed Martine Zimmermann to its board, effective September 8, 2026. Zimmermann previously served as executive vice president at Inventiva and has more than 30 years of industry experience. Maria Ostrovsky was appointed general counsel in October, effective November 3, 2026; she previously served as senior vice president, general counsel and chief compliance officer at Deciphera Pharmaceuticals, contributing to two global product launches.
